Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014775 |
| CAS No | NA |
| Mol.F. | C22H23N3O8S |
| Mol.Wt. | 489.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014776 |
| CAS No | NA |
| Mol.F. | C11H13N3O |
| Mol.Wt. | 203.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014777 |
| CAS No | NA |
| Mol.F. | C11H10BrN3O |
| Mol.Wt. | 280.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014778 |
| CAS No | NA |
| Mol.F. | C11H12BrN3O |
| Mol.Wt. | 282.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014779 |
| CAS No | NA |
| Mol.F. | C11H11BrN4O2 |
| Mol.Wt. | 311.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014780 |
| CAS No | NA |
| Mol.F. | C14H16BrN3O3 |
| Mol.Wt. | 354.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014781 |
| CAS No | NA |
| Mol.F. | C23H25FN4O2 |
| Mol.Wt. | 408.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014782 |
| CAS No | NA |
| Mol.F. | C14H18N4O |
| Mol.Wt. | 258.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014783 |
| CAS No | NA |
| Mol.F. | C22H28N2O7S |
| Mol.Wt. | 464.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014784 |
| CAS No | NA |
| Mol.F. | C10H6N2O5 |
| Mol.Wt. | 234.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014785 |
| CAS No | NA |
| Mol.F. | C12H8ClN3O3 |
| Mol.Wt. | 277.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N014786 |
| CAS No | NA |
| Mol.F. | C12H10ClN3O |
| Mol.Wt. | 247.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014787 |
| CAS No | NA |
| Mol.F. | C16H14ClN3O4 |
| Mol.Wt. | 347.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014788 |
| CAS No | NA |
| Mol.F. | C15H14ClN3O2 |
| Mol.Wt. | 303.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N014789 |
| CAS No | NA |
| Mol.F. | C17H16ClN3O4 |
| Mol.Wt. | 361.8 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014790 |
| CAS No | NA |
| Mol.F. | C9H13N7O5 |
| Mol.Wt. | 299.2 |
| INV STATUS | UNDER SYNTHESIS |